Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of GSK1557484A H5N1 Vaccine in Adults
NCT01788228Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 2013
- Primary completion
- Mar 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of influenza A (Q-Pan H5N1) virus monovalent vaccine (A/Indonesia) in Influenza A H5N1 (H5N1), sponsored by GSK. Started Mar 2013; status: completed.
02
Drugs
influenza A (Q-Pan H5N1) virus monovalent vaccine (A/Indonesia)
03
Conditions
Influenza A H5N1 (H5N1)
Beyond the preview
Go deeper on NCT01788228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01788228.